32, developed	13.961827491107185
16,608, participants	13.961827491107185
32, participants	13.961827491107185
follow-up, years	13.961827491107185
follow-up, of	13.26868031054724
cancer, developed	12.575533129987294
developed, found	12.015917342051871
cancer, ovarian	11.659242398113138
analysis, new	11.476920841319183
developed, years	10.870785037748869
5, years	10.665990625102856
The, analysis	10.324241331380799
analysis, found	10.324241331380799
of, participants	9.713332249057824
participants, the	9.407950599506643
developed, that	8.957881185161725
5, about	8.937946970260908
during, years	8.026933295487597
., found	5.734451984273149
ROOT, found	5.70729860916744
